These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 21642011)

  • 21. Non-competitive Inhibition of Nicotinic Acetylcholine Receptors by Ladybird Beetle Alkaloids.
    Leong RL; Xing H; Braekman JC; Kem WR
    Neurochem Res; 2015 Oct; 40(10):2078-86. PubMed ID: 25370792
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of [(125) I]epibatidine binding and nicotinic agonist-mediated (86) Rb(+) efflux in interpeduncular nucleus and inferior colliculus of beta2 null mutant mice.
    Marks MJ; Whiteaker P; Grady SR; Picciotto MR; McIntosh JM; Collins AC
    J Neurochem; 2002 Jun; 81(5):1102-15. PubMed ID: 12065623
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A robust homogeneous binding assay for alpha4beta2 nicotinic acetylcholine receptor.
    Hui X; Gao J; Xie X; Suto N; Ogiku T; Wang MW
    Acta Pharmacol Sin; 2005 Oct; 26(10):1175-80. PubMed ID: 16174432
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Agonist-induced up-regulation of alpha4beta2 nicotinic acetylcholine receptors in M10 cells: pharmacological and spatial definition.
    Whiteaker P; Sharples CG; Wonnacott S
    Mol Pharmacol; 1998 May; 53(5):950-62. PubMed ID: 9584223
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mouse beta-TC6 insulinoma cells: high expression of functional alpha3beta4 nicotinic receptors mediating membrane potential, intracellular calcium, and insulin release.
    Ohtani M; Oka T; Badyuk M; Xiao Y; Kellar KJ; Daly JW
    Mol Pharmacol; 2006 Mar; 69(3):899-907. PubMed ID: 16332988
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and structure-activity data of some new epibatidine analogues.
    Seerden JP; Tulp MT; Scheeren HW; Kruse CG
    Bioorg Med Chem; 1998 Nov; 6(11):2103-10. PubMed ID: 9881100
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Agonist regulation of rat alpha 3 beta 4 nicotinic acetylcholine receptors stably expressed in human embryonic kidney 293 cells.
    Meyer EL; Xiao Y; Kellar KJ
    Mol Pharmacol; 2001 Sep; 60(3):568-76. PubMed ID: 11502889
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular mechanisms and binding site location for the noncompetitive antagonist crystal violet on nicotinic acetylcholine receptors.
    Arias HR; Bhumireddy P; Spitzmaul G; Trudell JR; Bouzat C
    Biochemistry; 2006 Feb; 45(7):2014-26. PubMed ID: 16475790
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ligand specificity of nicotinic acetylcholine receptors in rat spinal cord: studies with nicotine and cytisine.
    Khan IM; Yaksh TL; Taylor P
    J Pharmacol Exp Ther; 1994 Jul; 270(1):159-66. PubMed ID: 8035312
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis, binding, and modeling studies of new cytisine derivatives, as ligands for neuronal nicotinic acetylcholine receptor subtypes.
    Tasso B; Canu Boido C; Terranova E; Gotti C; Riganti L; Clementi F; Artali R; Bombieri G; Meneghetti F; Sparatore F
    J Med Chem; 2009 Jul; 52(14):4345-57. PubMed ID: 19548687
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential expression of the beta4 neuronal nicotinic receptor subunit affects tolerance development and nicotinic binding sites following chronic nicotine treatment.
    Meyers EE; Loetz EC; Marks MJ
    Pharmacol Biochem Behav; 2015 Mar; 130():1-8. PubMed ID: 25560939
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence for spare nicotinic acetylcholine receptors and a beta 4 subunit in bovine adrenal chromaffin cells: studies using bromoacetylcholine, epibatidine, cytisine and mAb35.
    Wenger BW; Bryant DL; Boyd RT; McKay DB
    J Pharmacol Exp Ther; 1997 May; 281(2):905-13. PubMed ID: 9152400
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gene targeting demonstrates that alpha4 nicotinic acetylcholine receptor subunits contribute to expression of diverse [3H]epibatidine binding sites and components of biphasic 86Rb+ efflux with high and low sensitivity to stimulation by acetylcholine.
    Marks MJ; Meinerz NM; Drago J; Collins AC
    Neuropharmacology; 2007 Sep; 53(3):390-405. PubMed ID: 17631923
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Deletion of the alpha7, beta2, or beta4 nicotinic receptor subunit genes identifies highly expressed subtypes with relatively low affinity for [3H]epibatidine.
    Marks MJ; Whiteaker P; Collins AC
    Mol Pharmacol; 2006 Sep; 70(3):947-59. PubMed ID: 16728647
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ABT-594 [(R)-5-(2-azetidinylmethoxy)-2-chloropyridine]: a novel, orally effective analgesic acting via neuronal nicotinic acetylcholine receptors: I. In vitro characterization.
    Donnelly-Roberts DL; Puttfarcken PS; Kuntzweiler TA; Briggs CA; Anderson DJ; Campbell JE; Piattoni-Kaplan M; McKenna DG; Wasicak JT; Holladay MW; Williams M; Arneric SP
    J Pharmacol Exp Ther; 1998 May; 285(2):777-86. PubMed ID: 9580626
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interaction of d-tubocurarine analogs with the Torpedo nicotinic acetylcholine receptor. Methylation and stereoisomerization affect site-selective competitive binding and binding to the noncompetitive site.
    Pedersen SE; Papineni RV
    J Biol Chem; 1995 Dec; 270(52):31141-50. PubMed ID: 8537377
    [TBL] [Abstract][Full Text] [Related]  

  • 37. C3-halogenation of cytisine generates potent and efficacious nicotinic receptor agonists.
    Abin-Carriquiry JA; Voutilainen MH; Barik J; Cassels BK; Iturriaga-Vásquez P; Bermudez I; Durand C; Dajas F; Wonnacott S
    Eur J Pharmacol; 2006 Apr; 536(1-2):1-11. PubMed ID: 16563372
    [TBL] [Abstract][Full Text] [Related]  

  • 38. From ligand design to therapeutic efficacy: the challenge for nicotinic receptor research.
    Cassels BK; Bermúdez I; Dajas F; Abin-Carriquiry JA; Wonnacott S
    Drug Discov Today; 2005 Dec; 10(23-24):1657-65. PubMed ID: 16376826
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Site specificity of agonist-induced opening and desensitization of the Torpedo californica nicotinic acetylcholine receptor.
    Andreeva IE; Nirthanan S; Cohen JB; Pedersen SE
    Biochemistry; 2006 Jan; 45(1):195-204. PubMed ID: 16388595
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interaction of the catecholamine release-inhibitory peptide catestatin (human chromogranin A(352-372)) with the chromaffin cell surface and Torpedo electroplax: implications for nicotinic cholinergic antagonism.
    Taupenot L; Mahata SK; Mahata M; Parmer RJ; O'Connor DT
    Regul Pept; 2000 Nov; 95(1-3):9-17. PubMed ID: 11062327
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.